Position in VIR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,204,340
+$397,732 QoQ
Shares Held
134,413
+0.5% QoQ
Ownership
0.080%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VIR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Rafferty Asset Management, LLC holds $409,131,399 across 136 Biotechnology names. VIR ranks #91 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
54,572 | $24,368,580 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
29,589 | $22,861,644 | |
| 3 | INSM |
INSMED Inc
|
116,069 | $18,979,602 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
50,553 | $16,726,471 | |
| 5 | APLS |
Apellis Pharmaceuticals, Inc.
|
180,471 | $7,260,348 | |
| 6 | MRNA |
Moderna, Inc.
|
114,194 | $5,801,055 | |
| 7 | INCY |
Incyte Corp
|
60,565 | $5,700,377 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
10,452 | $5,471,308 |
All Filings in VIR
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,204,340 | 134,413 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $806,608 | 133,766 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $655,422 | 114,785 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $665,385 | 132,021 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,108,941 | 171,133 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $886,106 | 120,723 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,302,151 | 173,852 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,298,038 | 145,847 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $4,450,341 | 439,323 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $4,013,638 | 398,970 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $4,922,220 | 525,317 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $7,649,435 | 311,840 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $7,000,686 | 300,846 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $7,806,287 | 308,427 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $5,968,644 | 309,577 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,206,803 | 165,167 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $6,297,207 | 244,837 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $5,063,799 | 120,941 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $2,622,819 | 60,267 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $2,708,860 | 57,294 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $10,677,490 | 208,260 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $1,338,544 | 49,983 | Shares | Sole | 2021-02-10 | |
| No filing history on record for this holder in this stock. | ||||||